Axsome Therapeutics, Inc. (AXSM)
189.06
+4.56
(+2.47%)
USD |
NASDAQ |
Jan 21, 16:00
188.70
-0.36
(-0.19%)
After-Hours: 18:22
Axsome Therapeutics Free Cash Flow: -101.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Gilead Sciences, Inc. | 9.162B |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| Amicus Therapeutics, Inc. | 9.691M |
| MannKind Corp. | 42.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.046M |
| Cash from Investing (Quarterly) | -0.058M |
| Cash from Financing (Quarterly) | 21.27M |
| Free Cash Flow Per Share (Quarterly) | 0.0198 |
| Free Cash Flow to Equity (Quarterly) | 5.778M |
| Free Cash Flow to Firm (Quarterly) | 4.363M |
| Free Cash Flow Yield | -1.09% |